Andrew Galler
Stock Analyst at Morgan Stanley
(0.58)
# 4,040
Out of 4,981 analysts
29
Total ratings
33.33%
Success rate
-14.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Equal-Weight | $35 | $34.31 | +2.01% | 13 | Mar 7, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $7.73 | +94.05% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $4.57 | +294.30% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $28.67 | +29.05% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $61.10 | -8.35% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $4.79 | +275.78% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $58.98 | -8.44% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $76.33 | -34.49% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.20 | +1,275.00% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $23.88 | +1,173.03% | 1 | Nov 9, 2021 |
Immunocore Holdings
Mar 7, 2025
Assumes: Equal-Weight
Price Target: $35
Current: $34.31
Upside: +2.01%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $7.73
Upside: +94.05%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $4.57
Upside: +294.30%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $28.67
Upside: +29.05%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $61.10
Upside: -8.35%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $4.79
Upside: +275.78%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $58.98
Upside: -8.44%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $76.33
Upside: -34.49%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.20
Upside: +1,275.00%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $23.88
Upside: +1,173.03%